Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

Marvin Krohn-Grimberghe, Christoph Bode, Constantin von zur MuhlenDepartment of Cardiology and Angiology I, Heart Center, University of Freiburg, GermanyAbstract: Angioplasty and stent implantation have greatly improved the outcome of patients with acute coronary syndrome. However, stents come with...

Full description

Bibliographic Details
Main Authors:	Krohn-Grimberghe M, Bode C, von zur Muhlen C
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-05-01
Series:	Research Reports in Clinical Cardiology
Online Access:	http://www.dovepress.com/impact-of-rivaroxaban-on-stent-thrombosis-and-secondary-prevention-of--a16807

Similar Items

RIVAROXABAN IN LONG-TERM PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. V. Shalaev
Published: (2017-12-01)

Do Inpatients Receive Risk-Based Prophylactic Treatment for Thrombotic Events?
by: Armin Nemani, et al.
Published: (2021-04-01)

Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment
by: Murat Yuksel, et al.
Published: (2015-12-01)

Center Volumes Correlate with Likelihood of Stent Implantation in German Coronary Angiography
by: Vera Oettinger, et al.
Published: (2023-01-01)

Rivaroxaban for the treatment of cerebral venous thrombosis
by: Sara Esmaeili, et al.
Published: (2021-02-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)

Rivaroxaban for the treatment of saphenous vein graft thrombosis
by: Konstantinos Marmagkiolis, et al.
Published: (2016-07-01)

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
by: Ahrens I, et al.
Published: (2014-02-01)

Prevention of stent thrombosis: challenges and solutions
by: Reejhsinghani R, et al.
Published: (2015-01-01)

Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
by: A.V. Fonyakin, et al.
Published: (2014-05-01)

Early coronary stent thrombosis after bare metal stent implantation
by: Laxman Dubey, et al.
Published: (2014-01-01)

The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
by: Nina Haagenrud Schultz, et al.
Published: (2020-01-01)

Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes
by: Isra Marei, et al.
Published: (2022-10-01)

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
by: Hyeyoung Yang, et al.
Published: (2016-12-01)

An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
by: McAteer, M, et al.
Published: (2010)

Rivaroxaban in stable cardiovascular disease
by: Cahill, T, et al.
Published: (2018)

Novel nanostructured biomaterials: implications for coronary stent thrombosis
by: Karagkiozaki V, et al.
Published: (2012-12-01)

Triple, simultaneous, very late coronary stent thrombosis
by: Miguel Silva Vieira, et al.
Published: (2013-03-01)

THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING
by: N. A. Novikova, et al.
Published: (2017-05-01)

Acute stent thrombosis
by: Fahad Al Kindi, et al.
Published: (2014-01-01)

Sub-acute stent thrombosis secondary to ticagrelor resistance—Myth or reality!!
by: Pankaj Jariwala, et al.
Published: (2017-11-01)

Predictors of development of cardiovascular events after stenting of coronary arteries at patients with obesity
by: N. G Veselovskaya, et al.
Published: (2014-06-01)

Potential role of rivaroxaban in patients with acute coronary syndrome
by: Fitchett DH
Published: (2012-11-01)

Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice
by: Shivu GN, et al.
Published: (2014-05-01)

Evaluation of an in vitro coronary stent thrombosis model for preclinical assessment
by: Dylan Perry-Nguyen, et al.
Published: (2020-02-01)

The outcome of primary percutaneous coronary intervention in patients with stent thrombosis
by: Mukesh Kumar, et al.
Published: (2022-11-01)

Case Report: INTRAPROCEDURAL STENT THROMBOSIS IN PERCUTANEOUS CORONARY ANGIOPLASTY
by: Yudi Her Oktaviono
Published: (2017-08-01)

Coronary stent thrombosis: Beware of an allergic reaction and of Kounis syndrome
by: Nicholas G. Kounis, et al.
Published: (2014-03-01)

Late thrombosis of coronary bare-metal stent: Case report
by: Apostolović Svetlana, et al.
Published: (2006-01-01)

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
by: Menozzi Mila, et al.
Published: (2012-10-01)

RIVAROXABAN USE IN THE TREATMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM
by: A. D. Erlikh
Published: (2020-01-01)

Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention
by: Đurić Predrag, et al.
Published: (2016-01-01)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
by: Mitsuru Ishii, et al.
Published: (2022-11-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01)

EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
Published: (2016-03-01)

Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions
by: Larisa Anghel, et al.
Published: (2023-11-01)

Coronary Stent Thrombosis and Mortality: Does the Relationship Stand the Test of Time?
by: George V. Moukarbel
Published: (2022-04-01)

Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
by: Tamara Kovačević Preradovic, et al.
Published: (2023-01-01)

Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome
by: Özge Özcan Abacıoğlu, et al.
Published: (2022-02-01)